Welcome to the Mid-South Clinical Data Research Network

The Southern US has the highest rates of obesity, diabetes, cardiovascular disease, and significant rates of health disparities. The Mid-South Clinical Data Research Network (CDRN) centered at Vanderbilt University (VU) focuses on health systems in the Southern United States, but will include the capacity to reach a national population.

Our Focus

The Mid-South CDRN focuses on health systems that reach rural and urban populations. Our CDRN encompasses three large health systems:

  1. the Vanderbilt Health System which currently includes electronic medical records for over 2 million patients,
  2. the growing Vanderbilt Healthcare Affiliated Network (VHAN) which currently includes 45 hospitals, 300 ambulatory practices, and will cover over 3 million patients in the mid-South, and
  3. a partnership with Greenway Health and other national organizations to provide access to over 1600 practices and 16 million patients across the country.
  4. the Carolinas Collaborative which includes University of North Carolina at Chapel Hill, Duke University and Health Sciences South Carolina and reaches over 9 million patients.

Learn more

Tools & Research

The Mid-South CDRN is developing the tools and capacities to conduct pragmatic research that fits seamlessly into our healthcare operations. We have successfully utilized the EHR to capture rich clinical data which is essential for CER, and the performance of pragmatic clinical trials.

We are using Natural Language Processing to mine narrative text to create a more meticulous definition for cohort establishment and follow-up for pragmatic, randomized CER trials. Additionally, we are creating and expanding our novel informatics tools. The Mid-South CDRN will readily take on future projects in comparative effectiveness research and pragmatic clinical trials to answer practical clinical questions and to improve patient care.

Learn more

Follow us on social media:  

If you have any questions feel free to contact us via email.